MYP_085452
Unnamed
Anticancer
Antimicrobial
Antimicrobial
▸
Antibacterial
Cardiovascular
▸
Blood pressure regulation
▸
Antihypertensive
Delivery / Targeting
▸
Targeting ligand
▸
Targeting
Enzyme modulation
▸
Enzyme inhibition
Enzyme modulation
▸
Enzyme inhibition
▸
ACE inhibition
▸
ACE inhibitory
Enzyme modulation
▸
Enzyme inhibition
▸
DPP-IV inhibition
▸
DPP-IV inhibitory
Metabolic
▸
Glucose metabolism
▸
Standard
2 amino acids
C12H26N6O3
Standard
KR
302.37 Da
11.00
1.76
1.55
0.8796
-4.20
1.35
-2.02
168.00
0.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
180.34
-1.72
7.0
5.0
11.0
21.0
0.0
1.0
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0434497
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Escherichia coli ATCC 25922
256 μg/mL
MBEC (resazurin metabolic endpoint; Etafilcon A hydrogel contact lens (CL); MHB II)
RECORD: Rec_0434498
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Proteus mirabilis PCM 543
>512 μg/mL
MBEC (resazurin metabolic endpoint; polystyrene (PS); MHB II)
RECORD: Rec_0434499
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal tetradecanoylation (myristoyl, C14)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S4.
Bio-Activity Profile
-
Proteus mirabilis PCM 543
>512 μg/mL
MBEC (resazurin metabolic endpoint; Etafilcon A hydrogel contact lens (CL); MHB II)
RECORD: Rec_0434500
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal hexadecanoylation (palmitoyl, C16)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S8.
Bio-Activity Profile
-
Staphylococcus aureus ATCC 25923
8 μg/mL
MBFIC (resazurin metabolic endpoint; polystyrene (PS); MHB II)
RECORD: Rec_0434501
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
N-acylated synthetic dipeptide with linear peptide backbone [Linear]
reported L-amino-acid synthetic peptide [L]
N-terminal hexadecanoylation (palmitoyl, C16)
Amidation
Nα lipid-acylated Lys1 and C-terminal Arg carboxamide; complete reported molecular structure is in Figure S8.
Bio-Activity Profile
-
Staphylococcus aureus ATCC 25923
16 μg/mL
MBFIC (resazurin metabolic endpoint; Etafilcon A hydrogel contact lens (CL); MHB II)
Showing 5 records · Page 15 of 20